These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
378 related items for PubMed ID: 36773284
1. Effects of 12-week escitalopram treatment on resting-state functional connectivity of large-scale brain networks in major depressive disorder. Zhang S, Zhou J, Cui J, Zhang Z, Liu R, Feng Y, Feng L, Wang Y, Chen X, Wu H, Jin Y, Zhou Y, Wang G. Hum Brain Mapp; 2023 Apr 15; 44(6):2572-2584. PubMed ID: 36773284 [Abstract] [Full Text] [Related]
2. Effects of escitalopram therapy on resting-state functional connectivity of subsystems of the default mode network in unmedicated patients with major depressive disorder. Cui J, Wang Y, Liu R, Chen X, Zhang Z, Feng Y, Zhou J, Zhou Y, Wang G. Transl Psychiatry; 2021 Dec 13; 11(1):634. PubMed ID: 34903712 [Abstract] [Full Text] [Related]
3. Prediction of remission among patients with a major depressive disorder based on the resting-state functional connectivity of emotion regulation networks. Wu H, Liu R, Zhou J, Feng L, Wang Y, Chen X, Zhang Z, Cui J, Zhou Y, Wang G. Transl Psychiatry; 2022 Sep 17; 12(1):391. PubMed ID: 36115833 [Abstract] [Full Text] [Related]
4. Modulation of resting-state functional connectivity in default mode network is associated with the long-term treatment outcome in major depressive disorder. Ju Y, Wang M, Liu J, Liu B, Yan D, Lu X, Sun J, Dong Q, Zhang L, Guo H, Zhao F, Liao M, Zhang L, Zhang Y, Li L. Psychol Med; 2023 Oct 17; 53(13):5963-5975. PubMed ID: 36164996 [Abstract] [Full Text] [Related]
5. Effects of escitalopram therapy on effective connectivity among core brain networks in major depressive disorder. Wang Y, Zhou J, Chen X, Liu R, Zhang Z, Feng L, Feng Y, Wang G, Zhou Y. J Affect Disord; 2024 Apr 01; 350():39-48. PubMed ID: 38220106 [Abstract] [Full Text] [Related]
6. Eight-week antidepressant treatment reduces functional connectivity in first-episode drug-naïve patients with major depressive disorder. Li L, Su YA, Wu YK, Castellanos FX, Li K, Li JT, Si TM, Yan CG. Hum Brain Mapp; 2021 Jun 01; 42(8):2593-2605. PubMed ID: 33638263 [Abstract] [Full Text] [Related]
7. Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder. Martens MAG, Filippini N, Harmer CJ, Godlewska BR. Psychopharmacology (Berl); 2022 Nov 01; 239(11):3447-3460. PubMed ID: 34477887 [Abstract] [Full Text] [Related]
11. Mapping the effect of escitalopram treatment on amplitude of low-frequency fluctuations in patients with depression: a resting-state fMRI study. Wang L, Li X, Li K, Su Y, Zeng Y, Zhang Q, Wang G, Jin Z, Kong Q, Si T. Metab Brain Dis; 2017 Feb 01; 32(1):147-154. PubMed ID: 27524655 [Abstract] [Full Text] [Related]
12. Decreased functional connectivity in patients with major depressive disorder and a history of childhood traumatization through experiences of abuse. Schirmer ST, Beckmann FE, Gruber H, Schlaaff K, Scheermann D, Seidenbecher S, Metzger CD, Tempelmann C, Frodl T. Behav Brain Res; 2023 Feb 02; 437():114098. PubMed ID: 36067949 [Abstract] [Full Text] [Related]
13. Transcutaneous electrical cranial-auricular acupoint stimulation versus escitalopram for modulating the brain activity in mild to moderate major depressive disorder: An fMRI study. Ma Y, He J, Lu X, Sun J, Guo C, Luo Y, Gao S, Liu Y, Zhang Z, Rong P, Fang J. Neurosci Lett; 2023 Sep 25; 814():137414. PubMed ID: 37544579 [Abstract] [Full Text] [Related]
19. Shared and Unique Changes in Brain Connectivity Among Depressed Patients After Remission With Pharmacotherapy Versus Psychotherapy. Dunlop BW, Cha J, Choi KS, Rajendra JK, Nemeroff CB, Craighead WE, Mayberg HS. Am J Psychiatry; 2023 Mar 01; 180(3):218-229. PubMed ID: 36651624 [Abstract] [Full Text] [Related]